|
|
 |
|
Viewing report
|
|
|
|
An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology
HBS Consulting, May 2006
This latest Multi Client Publication provides:
- An overview of current industry-landscape for molecular diagnostics within the oncology area
- Analysis of the key European markets including forecasts for growth, drivers and restraints in the marketplace
- Reimbursement and legislation environment, the most relevant national guidelines relating to genetic testing
- Understanding of market opportunities for molecular diagnostics within the oncology market as an area of growth, research and future developments
- Data in Excel Spreadsheet
The primary objective of this report, compiled from an analysis of primary and secondary research data, is to
provide an overview of the molecular diagnostics market for selected oncology markers in the country markets
listed below.
- France
- Germany
- Italy
- United Kingdom
- USA
The following key issues have been addressed:
- Provide a reflective picture of the type and number of relevant testing institutions
- Which and how many parameters are tested (market size). Top 3 solid markers, top 3 lymphoid markers
and emerging markers identified.
- Which assays are used (home brew or commercial)
- Current market growth per parameter
- Expected market growth rates per parameter in the next 5 years
- Which technologies are used (PCR, RT-PCR, FISH, sequencing, microarrays, others) and what is the anticipated shift in use of these.
- Devices used
- The regulatory issues per country (legislation, reimbursement etc.)
- Future trends & emerging technologies
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
